Cargando…
Personalized radiotherapy of brain metastases: survival prediction by means of dichotomized or differentiated blood test results?
BACKGROUND AND OBJECTIVES: The validated LabBM score (laboratory parameters in patients with brain metastases) represents a widely applicable survival prediction model, which incorporates 5 blood test results (serum lactate dehydrogenase (LDH), C-reactive protein (CRP), albumin, platelets and hemogl...
Autores principales: | Nieder, Carsten, Andratschke, Nicolaus H., Grosu, Anca L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126728/ https://www.ncbi.nlm.nih.gov/pubmed/37114122 http://dx.doi.org/10.3389/fonc.2023.1156161 |
Ejemplares similares
-
Personalized treatment of brain metastases: Evolving survival prediction models may benefit from evaluation of serum tumor markers (narrative review)
por: Nieder, Carsten, et al.
Publicado: (2022) -
How we treat octogenarians with brain metastases
por: Nieder, Carsten, et al.
Publicado: (2023) -
Diagnosis-specific graded prognostic assessment score is valid in patients with brain metastases treated in routine clinical practice in two European countries
por: Nieder, Carsten, et al.
Publicado: (2012) -
Development of a Score Predicting Survival after Palliative Reirradiation
por: Nieder, Carsten, et al.
Publicado: (2014) -
Normal tissue studies in radiation oncology: A systematic review of highly cited articles and citation patterns
por: NIEDER, CARSTEN, et al.
Publicado: (2014)